[Hippocampal cAMP response element binding protein and antidepressant treatments]

Sheng Li Xue Bao. 2010 Dec 25;62(6):489-94.
[Article in Chinese]

Abstract

With the deepening research on pathogenesis of depression, the focus has diverted from the mechanism of regulating monoamines to the basic pathophysiology of depression and the long-term mechanism of antidepressant treatments. cAMP response element binding protein (CREB) in the brain, especially in the hippocampi, as a converging agent of many intracellular signaling transduction pathways is getting increasing attention. To better understand the basic pathophysiology of depression and the long-term mechanism of antidepressant treatments, it is significant to make clear the correlation between hippocampal CREB and antidepressant treatments. This review mainly refers to the formation of CREB and its distribution in hippocampi, the upstream signaling transduction pathways of hippocampal CREB and antidepressant treatments, and the possible antidepressant mechanisms by regulating hippocampal CREB.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antidepressive Agents / therapeutic use*
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • Depression / drug therapy*
  • Depression / physiopathology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Humans
  • Signal Transduction

Substances

  • Antidepressive Agents
  • Cyclic AMP Response Element-Binding Protein